A study on drug utilization pattern of anticoagulants in post-cardiac surgeries at a tertiary care hospital

Priya G. K.; Blessy K. George; Balakeshawa Ramaiah; Ramya M.

doi:10.18203/2319-2003.ijbcp20233903

Authors

Priya G. K. Department of Pharmacy Practice, Karnataka College of Pharmacy, Bangalore, Karnataka, India
Blessy K. George Department of Pharmacy Practice, Karnataka College of Pharmacy, Bangalore, Karnataka, India
Balakeshawa Ramaiah Department of Pharmacy Practice, Karnataka College of Pharmacy, Bangalore, Karnataka, India
Ramya M. Department of Pharmacy Practice, Karnataka College of Pharmacy, Bangalore, Karnataka, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20233903

Keywords:

Drug utilization pattern, Anticoagulants, Cardiac surgeries, Heparin, Warfarin, Valvular heart surgeries

Abstract

Background: The study is being carried out mainly to understand the prevention of coagulation of blood after a patient undergoing various types of cardiac surgeries, using different anticoagulation therapies suitable to particular types of cardiac surgery. This study was conducted to know the types of anticoagulants prescribed to patients who have undergone different types of cardiac surgeries along with the prescribed anticoagulants.

Methods: The study method used was a retrospective and prospective observational study carried out on 50 patients who underwent cardiac surgeries in the department of cardiology and medicine.

Results: A total of 50 patients were enrolled for this study who satisfied the inclusion criteria, out of which 64% of patients were males, and 36% were females. The highest number of patients were found to be in between the age group of 61-70 yrs (34%), whereas age group between 51-60 yrs (28%), age group 71 and above (18%), 41-50 (14%), 21-30 yrs (4%) and 18-20 yrs (2%) respectively. Most of the patients had undergone Coronary Artery bypass grafting. It was seen that the highest Anticoagulant being prescribed was Heparin in most of the post-cardiac surgeries. Whereas drugs like dalteparin, acenocoumarol, and warfarin were prescribed the majority in valvular heart surgeries.

Conclusions: Various cardiac surgeries were taken into consideration for the study. The most common anticoagulants prescribed were heparin, dalteparin, acenocoumarol, and warfarin in coronary artery bypass surgery and valvular heart surgeries respectively.

Metrics

Metrics Loading ...

References

Shalini S, Ravichandran V, Mohanty BK, Saraswathi R, Dhanaraj SK. A study of drug utilization pattern at dental outpatient department. Inter J Pharma Sci Nanotechnol. 2010;3(1):803-10.

Pendhari SR, Chaudhari DR, Burute SR, Bite BM. A Study on the drug utilization trends in cardiovascular emergencies in a tertiary care hospital. J Clin Diag Res. 2013;(4):666-70.

Barot PA, Malhotra SD, Rana DA, Patel VJ, Patel KP. Drug utilization in emergency medicine department at a tertiary care teaching hospital: a prospective study. J Basic Clin Pharma. 2013;4(4):78-81.

Aris A. Francisco Romero, the first heart surgeon. Ann Thorac Surg.1997;64(3):870-1.

Villareal RP, Hariharan R, Liu BC, Kar B, Lee VV, Elayda M. Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol. 2004;43(5):742-8.

Shrivastava R, Smith B, Caskey D, Reddy P. Atrial fibrillation after cardiac surgery: does prophylactic therapy decrease adverse outcomes associated with atrial fibrillation. J Intensive Care Med. 2009;24(1):18-25.

Almassi GH, Schowalter T, Nicolosi AC, Aggarwal A, Moritz TE, Henderson WG. Atrial fibrillation after cardiac surgery: a major morbid event? Ann Surg. 1997;226(4):501-11.

Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA. 2004; 291(14):1720-9.

Whitlock R, Healey JS, Connolly SJ, Wang J, Danter MR, Tu JV. Predictors of early and late stroke following cardiac surgery. CMAJ. 2014;186(12):905-11.

Roach GW, Kanchuger M, Mangano CM, Newman M, Nussmeier N, Wolman R. Adverse cerebral outcomes after coronary bypass surgery. Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators. N Engl J Med. 1996;335(25):1857-63.

Timm FP, Houle TT, Grabitz SD, Lihn AL, Stokholm JB, Eikermann-Haerter K. Migraine and risk of perioperative ischemic stroke and hospital readmission: hospital based registry study. BMJ. 2017; 356:6635.

O'Brien SM, Shahian DM, Filardo G, Ferraris VA, Haan CK, Rich JB. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. Ann Thorac Surg. 2009;88(1):S23-42.

Likosky DS, Marrin CA, Caplan LR, Baribeau YR, Morton JR, Weintraub RM. Determination of etiologic mechanisms of strokes secondary to coronary artery bypass graft surgery. Stroke. 2003;34(12):2830-4.

Tarakji KG, Sabik JF 3rd, Bhudia SK, Batizy LH, Blackstone EH. Temporal onset, risk factors, and outcomes associated with stroke after coronary artery bypass grafting. JAMA. 2011;305(4):381-90.

Chandalavada V, Gangula VNGM, Saikiran VVV, Medha GS. Drug Utilization Evaluation and Assessment of Economic Anticoagulants in a tertiary care hospital in south India. J Pharma Sci Innovat. 2018;(15):188-9.

Head JS, Bogers JJC, Kappetein AP. New Anticoagulants in Cardiac Surgery. Int Cardiol Rev. 2011;6(1):71-5.